Official UK procurement notice
Seasonal Influenza Vaccines 2025/2026
Authority: Regional Business Services Organisation Procurement and Logistics Service
What is being bought
Published requirement descriptionThis contract is for the procurement of a range of Seasonal Influenza Vaccines for the population of Northern Ireland
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Contract 5551307 is established under the Medicinal Products Dynamic Purchasing System…Awarded
Contract 5551307 is established under the Medicinal Products Dynamic Purchasing System (131864). This contract is for a range of Seasonal Influenza vaccines for the population of Northern Ireland.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (10)
- All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6): 10
- Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 10
- Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 4
- Categories A & B only: Product Makeup (Ovalbumin Content): 10
- All Categories (A, B, C, D): Product Makeup (Formaldehyde Content): 1
- All Categories (A, B, C, D): Product Makeup (Latex Status/Threat): 1
- All Categories (A, B, C, D): Supporting Information (Availability of PILs): 3
- All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales): 25
- Categories C & D only: Product Licence (Age Group Coverage): 16
- price: 40
Published award criteria (14)
- All Categories (A, B, C, D): Compliance with Contract Scope and Specification: Pass/Fail
- All Categories (A, B, C, D): Registration on the NHS Evergreen Sustainable Supplier Assessment platform: Pass/Fail
- All Categories (A, B, C, D): Supply and Delivery of Product (GDP Compliance): Pass/Fail
- All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 1): Pass/Fail
- All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6): 10%
- Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 10%
- Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle): 4%
- Categories A & B only: Product Makeup (Ovalbumin Content): 10%
- All Categories (A, B, C, D): Product Makeup (Formaldehyde Content): 1%
- All Categories (A, B, C, D): Product Makeup (Latex Status/Threat): 1%
- All Categories (A, B, C, D): Supporting Information (Availability of PILs): 3%
- All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales): 25%
- Categories C & D only: Product Licence (Age Group Coverage): 16%
- Price: 40%
- Price carries 40 of 120 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Restricted procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 1 May 2025, 15:51 BST
- Last source update
- 1 May 2025, 15:51 BST
- Authority reference
5551307- FTS notice number
2025/S 000-018527- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-050ba9Find a Tender
Publisher note: The figure in V.2.4 is the awarded figure based on volume of doses agreed at the time of tender award. However, should there be a requirement for additional volumes, the Authority reserves the right to purchase further volumes up to a combined overall maximum value of £7862500 which accounts for the tendered cost associated with the maximum volume of doses set out in the tender documentation. Should additional product be required under this contract, the maximum value of combined purchases shall not exceed £7862500.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Seqirus UK LtdSeasonal Influenza Vaccines 2025/26 | £5,166,140 † | — | Awarded |
Contracts
Seasonal Influenza Vaccines 2025/26 · Seqirus UK Ltd
- Signed
- 2 Apr 2025
- Value
- £5,166,140
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Business Services Organisation, PaLSReview body
Bidders & participating suppliers
1 commercial party on the notice- Seqirus UK LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.